The study of inflammatory bowel disease, including Ulcerative Colitis and Crohn's Disease, has relied largely upon the use of animal or cell culture models; neither of which can represent all aspects of the human pathophysiology. Presented herein is a dual flow microfluidic device which holds full thickness human intestinal tissue in a known orientation. The luminal and serosal sides are independently perfused ex vivo with nutrients with simultaneous waste removal for up to 72 h. The microfluidic device maintains the viability and integrity of the tissue as demonstrated through Haematoxylin & Eosin staining, immunohistochemistry and release of lactate dehydrogenase. In addition, the inflammatory state remains in the tissue after perfusion on the device as determined by measuring calprotectin levels. It is anticipated that this human model will be extremely useful for studying the biology and testing novel interventions in diseased tissue.
References
1.
M. Z.
Cader
and A.
Kaser
, “Recent advances in inflammatory bowel disease: Mucosal immune cells in intestinal inflammation
,” Gut
62
(11
), 1653
–1664
(2013
).2.
S.
Danese
, “New therapies for inflammatory bowel disease: From the bench to the bedside
,” Gut
61
(6
), 918
–932
(2012
).3.
S. G.
Nugent
, D.
Kumar
, D. S.
Rampton
, and D. F.
Evans
, “Intestinal luminal pH in inflammatory bowel disease: Possible determinants and implications for therapy with aminosalicylates and other drugs
,” Gut
48
(4
), 571
–577
(2001
).4.
S. B.
Hanauer
, “Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunities
,” Inflammatory Bowel Dis.
12
(5
), S3
–S9
(2006
).5.
F.
Shanahan
, “Probiotics and inflammatory bowel disease: Is there a scientific rationale?
,” Inflammatory Bowel Dis.
6
(2
), 107
–115
(2000
).6.
K.
Tsilingiri
, T.
Barbosa
, G.
Penna
et al., “Probiotic and postbiotic activity in health and disease: Comparison on a novel polarised ex-vivo organ culture model
,” Gut
61
(7
), 1007
–1015
(2012
).7.
A. N.
Ananthakrishnan
, S. C.
Cheng
, T.
Cai
et al., “Serum inflammatory markers and risk of colorectal cancer in patients with inflammatory bowel diseases
,” Clin. Gastroenterol. Hepatol.
12
(8
), 1342-8.e1
(2014
).8.
A.
Boleij
and H.
Tjalsma
, “Gut bacteria in health and disease: a survey on the interface between intestinal microbiology and colorectal cancer
,” Biol. Rev.
87
(3
), 701
–730
(2012
).9.
S. H.
Itzkowitz
and D. H.
Present
“Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease
,” Inflammatory Bowel Dis.
11
(3
), 314
–321
(2005
).10.
J. K.
Triantafillidis
, G.
Nasioulas
, and P. A.
Kosmidis
, “Colorectal cancer and inflammatory bowel disease: Epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies
,” Anticancer Res.
29
(7
), 2727
–2737
(2009
).11.
B.
Chassaing
, J. D.
Aitken
, M.
Malleshappa
, and M.
Vijay-Kumar
, “Dextran sulfate sodium (DSS)-induced colitis in mice
,” Curr. Protoc. Immunol.
104
(15.25), 15.25.1
–15.25.14
(2014
).12.
C. R.
Kleiveland
, L. T. O.
Hult
, S.
Spetalen
et al., “The noncommensal Bacterium Methylococcus capsulatus (Bath) ameliorates dextran sulfate (sodium salt)-induced ulcerative colitis by influencing mechanisms essential for maintenance of the colonic barrier function
,” Appl. Environ. Microbiol.
79
(1
), 48
–56
(2013
).13.
P. S.
Dulai
, C. A.
Siegel
, J.-F.
Colombel
, W. J.
Sandborn
, and L.
Peyrin-Biroulet
, “Systematic review: Monotherapy with antitumour necrosis factor α agents versus combination therapy with an immunosuppressive for IBD
,” Gut
63
(12
), 1843
–1853
(2014
).14.
C. J.
Bettinger
and J. T.
Borenstein
, “Biomaterials-based microfluidics for engineered tissue constructs
,” Soft Matter
6
(20
), 4999
–5015
(2010
).15.
H. J.
Kim
and D. E.
Ingber
, “Gut-on-a-chip microenvironment induces human intestinal cells to undergo villus differentiation
,” Integr. Biol.
5
(9
), 1130
–1140
(2013
).16.
A.
Ponder
and M. D.
Long
, “A clinical review of recent findings in the epidemiology of inflammatory bowel disease
,” Clin. Epidemiol.
5
, 237
–247
(2013
).17.
H. J.
Kim
, D.
Huh
, G.
Hamilton
, and D. E.
Ingber
, “Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow
,” Lab Chip
12
(12
), 2165
–2174
(2012
).18.
L. L.
Clarke
, “A guide to Ussing chamber studies of mouse intestine
,” Am. J. Physiol. Gastrointest. Liver Physiol.
296
(6
), G1151
–G1166
(2009
).19.
K. W.
Lomasney
and N. P.
Hyland
, “The application of Ussing chambers for determining the impact of microbes and probiotics on intestinal ion transport
,” Can. J. Physiol. Pharmacol.
91
(9
), 663
–670
(2013
).20.
E.
Rodrigues
, L.
Slobbe
, M.
Schultz
, and G.
Butt
, “Chronic exposure to microbial stimuli affects the development of the intestinal epithelium in human colonic enteroids
,” FASEB J.
29
, 26
–28
(2015
).21.
I.
Maschmeyer
, A. K.
Lorenz
, K.
Schimek
et al., “A four-organ-chip for interconnected long-term co-culture of human intestine, liver, skin and kidney equivalents
,” Lab Chip
15
(12
), 2688
–2699
(2015
).22.
M.
Baker
, “Tissue models: A living system on a chip
,” Nature
471
(7340
), 661
–665
(2011
).23.
S.
Hattersley
, D.
Sylvester
, C.
Dyer
, N.
Stafford
, S.
Haswell
, and J.
Greenman
, “A microfluidic system for testing the responses of head and neck squamous cell carcinoma tissue biopsies to treatment with chemotherapy drugs
,” Ann. Biomed. Eng.
40
(6
), 1277
–1288
(2012
).24.
S. M.
Hattersley
, C. E.
Dyer
, J.
Greenman
, and S. J.
Haswell
, “Development of a microfluidic device for the maintenance and interrogation of viable tissue biopsies
,” Lab Chip
8
(11
), 1842
–1846
(2008
).25.
S. M.
Hattersley
, J.
Greenman
, and S. J.
Haswell
, “Study of ethanol induced toxicity in liver explants using microfluidic devices
,” Biomed. Microdevices
13
(6
), 1005
–1014
(2011
).26.
S. M.
Hattersley
, J.
Greenman
, and S. J.
Haswell
, “The application of microfluidic devices for viral diagnosis in developing countries
,” Methods Mol. Biol.
949
, 285
–303
(2013
).27.
E.
Cuevas
, D. B.
Jones
, and D. H.
Wright
, “Immunohistochemical detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues
,” J. Pathol.
169
(4
), 477
–478
(1993
).28.
R.
Najafi
and S. M.
Bernard
, “Use of physiologically balanced, ionized, acidic solution in wound healing
,” U.S. patent US6426066 B1 (30 July 2002
).29.
J.
Westerhout
, E.
van de Steeg
, D.
Grossouw
et al., “A new approach to predict human intestinal absorption using porcine intestinal tissue and biorelevant matrices
,” Eur. J. Pharm. Sci.
63
, 167
–177
(2014
).30.
A.
Webster
, C. E.
Dyer
, S. J.
Haswell
, and J.
Greenman
, “A microfluidic device for tissue biopsy culture and interrogation
,” Anal. Methods
2
(8
), 1005
–1007
(2010
).31.
J.
Woods
, P. T.
Docker
, C. E.
Dyer
, S. J.
Haswell
, and J.
Greenman
, “On-chip integrated labelling, transport and detection of tumour cells
,” Electrophoresis
32
(22
), 3188
–3195
(2011
).32.
M.
Schaubeck
, T.
Clavel
, J.
Calasan
et al., “Dysbiotic gut microbiota causes transmissible Crohn's disease-like ileitis independent of failure in antimicrobial defence
,” Gut
65
(2
), 225
–237
(2016
).33.
D.
Sylvester
, S. M.
Hattersley
, N. D.
Stafford
, S. J.
Haswell
, and J.
Greenman
, “Development of microfluidic-based analytical methodology for studying the effects of chemotherapy agents on cancer tissue
,” Current Analyt. Chem.
9
(1
), 2
–8
(2013
).34.
D. T.
Rubin
, “The rationale and growth of advanced training in inflammatory bowel disease
,” Gastroenterology
148
(4
), 696
–700
(2015
).35.
S. C.
Ng
, C. N.
Bernstein
, M. H.
Vatn
et al., “Geographical variability and environmental risk factors in inflammatory bowel disease
,” Gut
62
(4
), 630
–649
(2013
).36.
E.-M.
Materne
, I.
Maschmeyer
, A. K.
Lorenz
et al., “The multi-organ chip - A microfluidic platform for long-term multi-tissue coculture
,” J. Vis. Exp.
98
, e52526
(2015
).37.
A. D.
van der Meer
and A.
van den Berg
, “Organs-on-chips: breaking the in vitro impasse
,” Integr. Biol.
4
(5
), 461
–470
(2012
).38.
A.
Williamson
, S.
Singh
, U.
Fernekorn
, and A.
Schober
, “The future of the patient-specific body-on-a-chip
,” Lab Chip
13
(18
), 3471
–3480
(2013
).39.
P.
Loskill
, S. G.
Marcus
, A.
Mathur
, W. M.
Reese
, and K. E.
Healy
, “μOrgano: A Lego™ like plug & play system for modular multi-organ-chips
,” PLoS One
10
(10
), e0139587
(2015
).© 2016 Author(s).
2016
Author(s)
You do not currently have access to this content.
